Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,766,960
-
Total 13F shares
-
23,389,191
-
Share change
-
-178,928
-
Total reported value
-
$10,723,496,299
-
Put/Call ratio
-
77%
-
Price per share
-
$458.66
-
Number of holders
-
352
-
Value change
-
-$21,867,277
-
Number of buys
-
190
-
Number of sells
-
144
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q3 2025
As of 30 Sep 2025,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by
352 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,389,191 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, PAULSON & CO. INC., JANUS HENDERSON GROUP PLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC.
This page lists
352
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.